{"transactions":[{"id":3211459,"issuer":{"id":5247,"kind":"organization","name":"GYRE THERAPEUTICS, INC."},"owners":[{"id":150663,"kind":"person","name":"Richard John P","position":1,"cik":"0001296528","reported_name":"Richard John P","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-03-13T22:56:17.000Z","date":"2020-03-13","kind":"purchase","acquired":true,"shares":2500,"price":3.98,"value":9950.0,"ownership":{"direct":true},"balance_after":3716,"source":{"system":"sec-edgar","filing":"0001209191-20-019038","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1124105/000120919120019038/doc4.xml","form_type":"4"}},{"id":3394081,"issuer":{"id":6654,"kind":"organization","name":"Vaxart, Inc."},"owners":[{"id":150663,"kind":"person","name":"Richard John P","position":1,"cik":"0001296528","reported_name":"Richard John P","relationship":{"director":true}}],"security":"Common stock","published_at":"2019-10-15T16:19:57.000Z","date":"2019-10-11","kind":"purchase","acquired":true,"shares":20000,"price":0.384,"value":7680.0,"ownership":{"direct":true},"balance_after":20000,"source":{"system":"sec-edgar","filing":"0001437749-19-020035","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/72444/000143774919020035/rdgdoc.xml","form_type":"4"}},{"id":3488284,"issuer":{"id":5247,"kind":"organization","name":"GYRE THERAPEUTICS, INC."},"owners":[{"id":150663,"kind":"person","name":"Richard John P","position":1,"cik":"0001296528","reported_name":"Richard John P","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2019-06-18T01:13:25.000Z","date":"2019-06-13","kind":"grant","acquired":true,"shares":5000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option shall vest monthly over a period of 12 months commencing June 13, 2019."}],"balance_after":5000,"derivative":{"exercise_price":7.46,"exercise_date":"2020-06-13","expiration_date":"2029-06-13","underlying":"Common Stock","underlying_shares":5000},"source":{"system":"sec-edgar","filing":"0001209191-19-037569","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1124105/000120919119037569/doc4.xml","form_type":"4"}},{"id":3490771,"issuer":{"id":6654,"kind":"organization","name":"Vaxart, Inc."},"owners":[{"id":150663,"kind":"person","name":"Richard John P","position":1,"cik":"0001296528","reported_name":"Richard John P","relationship":{"director":true}}],"security":"Stock Option (right to buy)","published_at":"2019-06-14T20:33:01.000Z","date":"2019-06-12","kind":"grant","acquired":true,"shares":12700,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares subject to this option shall vest on the first anniversary of the 2019 annual meeting of stockholders of the Issuer."}],"balance_after":12700,"derivative":{"exercise_price":0.68,"exercise_date":"2020-04-22","expiration_date":"2029-06-11","underlying":"Common Stock","underlying_shares":12700},"source":{"system":"sec-edgar","filing":"0001437749-19-012099","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/72444/000143774919012099/rdgdoc.xml","form_type":"4"}},{"id":3490770,"issuer":{"id":6654,"kind":"organization","name":"Vaxart, Inc."},"owners":[{"id":150663,"kind":"person","name":"Richard John P","position":1,"cik":"0001296528","reported_name":"Richard John P","relationship":{"director":true}}],"security":"Stock Option (right to buy)","published_at":"2019-06-14T20:33:01.000Z","date":"2019-06-12","kind":"grant","acquired":true,"shares":9000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to this option shall vest annually over three years from the vesting commencement date of February 13, 2018 (the closing date of the merger between privately-held Vaxart, Inc. and Aviragen Therapeutics, Inc.)."}],"balance_after":9000,"derivative":{"exercise_price":0.68,"expiration_date":"2029-06-11","underlying":"Common Stock","underlying_shares":9000},"source":{"system":"sec-edgar","filing":"0001437749-19-012099","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/72444/000143774919012099/rdgdoc.xml","form_type":"4"}},{"id":3510484,"issuer":{"id":5247,"kind":"organization","name":"GYRE THERAPEUTICS, INC."},"owners":[{"id":150663,"kind":"person","name":"Richard John P","position":1,"cik":"0001296528","reported_name":"Richard John P","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-05-28T13:45:10.000Z","date":"2019-05-24","kind":"purchase","acquired":true,"shares":1000,"price":8.03,"value":8030.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $8.02 to $8.03, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote to this Form 4."}],"balance_after":1216,"source":{"system":"sec-edgar","filing":"0001209191-19-032871","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1124105/000120919119032871/doc4.xml","form_type":"4"}},{"id":3892774,"issuer":{"id":5247,"kind":"organization","name":"GYRE THERAPEUTICS, INC."},"owners":[{"id":150663,"kind":"person","name":"Richard John P","position":1,"cik":"0001296528","reported_name":"Richard John P","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2018-06-15T21:56:25.000Z","date":"2018-06-13","kind":"grant","acquired":true,"shares":5000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option shall vest monthly over a period of 12 months commencing June 13, 2018."}],"balance_after":5000,"derivative":{"exercise_price":24.94,"exercise_date":"2019-06-13","expiration_date":"2028-06-13","underlying":"Common Stock","underlying_shares":5000},"source":{"system":"sec-edgar","filing":"0001209191-18-038138","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1124105/000120919118038138/doc4.xml","form_type":"4"}},{"id":4040965,"issuer":{"id":5247,"kind":"organization","name":"GYRE THERAPEUTICS, INC."},"owners":[{"id":150663,"kind":"person","name":"Richard John P","position":1,"cik":"0001296528","reported_name":"Richard John P","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Redeemable Convertible Note","published_at":"2018-02-22T21:36:00.000Z","date":"2018-02-20","kind":"other","acquired":false,"price":0,"reported_value":16559,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Reflects a 1:15 reverse stock split effected on February 10, 2017."},{"field":"kind","element":"transactionCoding","label":"F2","text":"Reflects a redeemable convertible note of the Issuer (the \"Note\") that matured, with the face value of the Note repaid to the Reporting Person."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"At the option of the Reporting Person, at any time on or before February 19, 2018, the Note was redeemable into cash at a rate of $1 for each $1 principal amount of the Note or convertible into shares of common stock of the Issuer at a conversion rate of $137.85 per share, respectively."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"The Note matured on February 19, 2018."}],"derivative":{"exercise_price":137.85,"underlying":"Common Stock","underlying_shares":120},"source":{"system":"sec-edgar","filing":"0001209191-18-012450","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1124105/000120919118012450/doc4.xml","form_type":"4"}},{"id":4122627,"issuer":{"id":5247,"kind":"organization","name":"GYRE THERAPEUTICS, INC."},"owners":[{"id":150663,"kind":"person","name":"Richard John P","position":1,"cik":"0001296528","reported_name":"Richard John P","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Redeemable Convertible Note","published_at":"2017-12-22T22:00:26.000Z","date":"2017-12-20","kind":"other","acquired":false,"price":0,"reported_value":8100,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Reflects a redeemable convertible note of the Issuer (the \"Note\") that was called for redemption by the Reporting Person at a price equal to its face value."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"At the option of the Reporting Person, at any time on or before February 19, 2018, the Note shall be redeemable into cash at a rate of $1 for each $1 principal amount of the Note or convertible into shares of common stock of the Issuer at a conversion rate of $137.85 per share, respectively."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The Note will mature on February 19, 2018."}],"derivative":{"exercise_price":9.19,"underlying":"Common Stock","underlying_shares":58},"source":{"system":"sec-edgar","filing":"0001209191-17-067088","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1124105/000120919117067088/doc4.xml","form_type":"4"}},{"id":4256550,"issuer":{"id":5247,"kind":"organization","name":"GYRE THERAPEUTICS, INC."},"owners":[{"id":150663,"kind":"person","name":"Richard John P","position":1,"cik":"0001296528","reported_name":"Richard John P","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2017-07-17T15:25:56.000Z","date":"2017-07-13","kind":"grant","acquired":true,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option shall vest monthly over a period of 12 months commencing June 15, 2017."}],"balance_after":10000,"derivative":{"exercise_price":4.4,"exercise_date":"2018-06-15","expiration_date":"2027-07-13","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001209191-17-045311","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1124105/000120919117045311/doc4.xml","form_type":"4"}},{"id":4311157,"issuer":{"id":6654,"kind":"organization","name":"Vaxart, Inc."},"owners":[{"id":150663,"kind":"person","name":"Richard John P","position":1,"cik":"0001296528","reported_name":"Richard John P","relationship":{"director":true}}],"security":"Stock Option (Right to Buy)","published_at":"2017-05-22T19:30:08.000Z","date":"2017-05-18","kind":"grant","acquired":true,"shares":20000,"price":0.49,"value":9800.0,"ownership":{"direct":true},"balance_after":105000,"derivative":{"exercise_price":0.49,"exercise_date":"2018-05-18","expiration_date":"2027-05-18","underlying":"Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001437749-17-009783","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/72444/000143774917009783/rdgdoc.xml","form_type":"4"}}]}